Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19.
- DOI
- 10.1002/prp2.1083
- Published
- 2023 Apr
- Container
- Pharmacology research & perspectives
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/prp2.1083,
title = {Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19.},
author = {Rothlin RP and Pelorosso FG and Duarte M and Nicolosi L and Ignacio FC and Salgado MV and Vetulli H},
year = {2023},
journal = {Pharmacology research \& perspectives},
doi = {10.1002/prp2.1083},
url = {https://doi.org/10.1002/prp2.1083}
}RIS
TY - JOUR TI - Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19. AU - Rothlin RP AU - Pelorosso FG AU - Duarte M AU - Nicolosi L AU - Ignacio FC AU - Salgado MV AU - Vetulli H PY - 2023 JO - Pharmacology research & perspectives DO - 10.1002/prp2.1083 UR - https://doi.org/10.1002/prp2.1083 ER -
APA
RP, R., FG, P., M, D., L, N., FC, I., MV, S., & H, V. (2023). Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19.. Pharmacology research & perspectives. https://doi.org/10.1002/prp2.1083
Source records
- pubmed · retrieved 2026-09-27T16:19:42.639Z
- europe-pmc · retrieved 2026-09-27T16:19:42.653Z
- doaj · retrieved 2026-09-27T16:19:42.636Z